title: Efficacy of diverse high-dose regimens followed by autologous peripheral blood stem cell transplantation in consecutive multiple myeloma patients: a single-centre analysis over a 12-year period.
authors.forename: P S
authors.initials: PS
authors.lastname: Haas
authors.forename: K
authors.initials: K
authors.lastname: Bauchmüller
authors.forename: A
authors.initials: A
authors.lastname: Kühnemund
authors.forename: J
authors.initials: J
authors.lastname: Finke
authors.forename: G
authors.initials: G
authors.lastname: Ihorst
authors.forename: M
authors.initials: M
authors.lastname: Engelhardt
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002330:Carmustine / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D009101:Multiple Myeloma / Q000401:mortality / Q000628:therapy*; D036102:Peripheral Blood Stem Cell Transplantation; D011034:Podophyllotoxin / Q000008:administration & dosage; D012074:Remission Induction; D012189:Retrospective Studies; D014182:Transplantation, Autologous
chemical_list: D003561:Cytarabine; D011034:Podophyllotoxin; D008558:Melphalan; D002330:Carmustine